How severe is CVE-2022-41945?

CVE-2022-41945 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over local access with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2022-41945 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (51st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-41945?

CVE-2022-41945 affects Super-xray Project Super-xray. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-41945?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2022-41945 published?

CVE-2022-41945 was published on 2022-11-21 and last updated on 2026-06-17.

CVE-2022-41945

CVE-2022-41945 is a medium-severity vulnerability in Super-xray Project Super-xray with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-94.

Key facts

Severity: Medium (CVSS 3.x base score 6.5)
EPSS exploit prediction: 1% (51st percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-94
Affected product: Super-xray Project Super-xray
Published: 2022-11-21
Last modified: 2026-06-17

Description

super-xray is a vulnerability scanner (xray) GUI launcher. In version 0.1-beta, the URL is not filtered and directly spliced into the command, resulting in a possible RCE vulnerability. Users should upgrade to super-xray 0.2-beta.

Frequently asked questions

What is CVE-2022-41945?: super-xray is a vulnerability scanner (xray) GUI launcher. In version 0.1-beta, the URL is not filtered and directly spliced into the command, resulting in a possible RCE vulnerability. Users should upgrade to super-xray 0.2-beta.
How severe is CVE-2022-41945?: CVE-2022-41945 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over local access with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-41945 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (51st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-41945?: CVE-2022-41945 affects Super-xray Project Super-xray. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-41945?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2022-41945 published?: CVE-2022-41945 was published on 2022-11-21 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:super-xray_project:super-xray:0.1:beta:*:*:*:*:*:*

Other CWE-94 (Code Injection) vulnerabilities

CVE-2026-57624 — Critical (CVSS 10.0): Unauthenticated Remote Code Execution (RCE) in Blocksy Companion Pro <= 2.1.46 versions.
CVE-2026-10134 — Critical (CVSS 10.0): IBM Langflow OSS 1.0.0 through 1.9.3 allows an attacker to read every secret available to the Langflow process, read…
CVE-2026-53576 — Critical (CVSS 10.0): Kestra is an open-source, event-driven orchestration platform. Prior to 1.0.45 and 1.3.21, the authentication filter…
CVE-2026-10561 — Critical (CVSS 10.0): IBM Langflow OSS 1.0.0 through 1.9.3 has an vulnerability due to an improper isolation of Python execution combined…
CVE-2026-25470 — Critical (CVSS 10.0): Improper Control of Generation of Code ('Code Injection') vulnerability in ACPT ACPT (Pro) - Custom Post Types Plugin…
CVE-2026-48836 — Critical (CVSS 10.0): Unauthenticated Remote Code Execution (RCE) in Easy Invoice <= 2.1.19 versions.

Browse all CWE-94 (Code Injection) vulnerabilities →